Empagliflozin in newly untreated type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a medication called empagliflozin (a type 2 diabetes pill) to see how well it works in people with type 2 diabetes who have not taken any diabetes drugs for at least 8 weeks. If you qualify, you may receive the study drug and help researchers learn more about managing blood sugar.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes and are not on any diabetes medications for at least 8 weeks.
- Your recent blood sugar test (HbA1c) is between 6.5% and 10.0%.
- You are between 20 and 75 years old.
- Your body mass index (BMI) is 18.5 to 39.9.
- You do not have certain serious heart, liver, kidney, or cancer problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well and how safely empagliflozin works in real-world care for adults with type 2 diabetes who are not controlled on current pill treatment. Some participants take it with metformin, and the study helps confirm what to expect in everyday patients.
This trial tests whether adding empagliflozin (a diabetes pill) to your current medicines (alogliptin and metformin) helps manage blood sugar better. It may be an option if your blood sugar is not well controlled with your current treatment.
This trial tests a new combination pill (henagliflozin and metformin) compared to metformin alone in people recently diagnosed with type 2 diabetes. The goal is to see which treatment works better and is safer.
This trial tests two diabetes medications—empagliflozin and glimepiride—used together to see if the combination works better and is safe for people with type 2 diabetes. If you're already on diabetes pills, this could help improve your blood sugar control.
This trial tests a medicine called empagliflozin (usually used for diabetes) to see if it can help people with very advanced kidney disease and diabetes. The study will check if this drug can slow down further kidney damage and improve overall kidney health.
This trial tests how combining a ketone supplement with certain diabetes medicines affects blood sugar and ketone levels. It may help adults with type 2 diabetes who are not on insulin or certain other drugs.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.